Group 1 - The company, Aoke Co., Ltd., is currently in the process of applying for the approval of its self-developed active pharmaceutical ingredient, polyethylene glycol 3350, which is intended for use in medications for treating constipation or preoperative bowel cleansing [2] - The polyethylene glycol 3350 products, including the compound polyethylene glycol (3350) electrolyte powder, are specifically designed for the treatment of constipation [2] - The active pharmaceutical ingredient is still in the review and approval stage and has not yet been launched for sale [2]